{
    "clinical_study": {
        "@rank": "75716", 
        "arm_group": [
            {
                "arm_group_label": "FERTILE GROUP", 
                "description": "WOMEN HAVE NO INFERTILITY PROBLEMS AND HAVE AT LEAST ONE CHILD"
            }, 
            {
                "arm_group_label": "UNEXPLAINED INFERTILE GROUP", 
                "description": "WOMEN WITH INFERTILITY PROBLEMS,NO HISTORY OF PREGNANCY AND HAVE NO CHILDREN"
            }
        ], 
        "biospec_descr": {
            "textblock": "SERUM SAMPLES OF PATIENTS WILL BE STORED .THE SERUM SAMPLES DO NOT CONTAIN DNA."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "IN UNEXPLAINED INFERTILITY IN  WOMEN ,OVARY RESERVE IS BORDERLINE IF  ASSESSED USING\n      HIGH-SENSITIVE TESTS."
        }, 
        "brief_title": "Assessment of Ovarian Reserve Tests in Unexplained Infertile Women", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Infertility", 
            "Infertility, Female"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Infertility, Female"
            ]
        }, 
        "detailed_description": {
            "textblock": "IN UNEXPLAINED INFERTILITY OVARIAN RESERVE TESTS  WERE ASSESSED.\n\n      IN THIS STUDY, A COMPARISON IS DONE BETWEEN 35 WOMEN WITH UNEXPLAINED FERTILITY(THE PATIENT)\n       AND 35 WOMEN  WHO DON'T HAVE ANY FERTILITY PROBLEMS AND HAVE AT LEAST A CHILD (THE CONTROL\n      GROUP).\n\n      THE STUDY PARTICIPANTS SHOULD HAVE THE FOLLOWING CRITERIA\n\n      Inclusion Criteria:\n\n      LESS THAN 35 YEARS OLD, MARRIED WOMEN SHOULD HAVE REGULAR MENSES SHOULD HAVE AT LEAST A YEAR\n      OF UNPROTECTED SEX. THE HUSBAND'S SPERMOGRAM SHOULD HAVE NO ABNORMALITIES THE  SUBJECT\n      SHOULD HAVE A NORMAL HYSTEROSALPHINGOGRAPHY\n\n      Exclusion Criteria:\n\n      HAVING ANY SYSTEMIC DISEASE. LONG HISTORY OF ANY DRUG USAGE.\n\n      FOR THE CONTROL GROUP\n\n      Inclusion Criteria:\n\n      LESS THAN 35 YEARS OLD, MARRIED WOMEN SHOULD HAVE REGULAR MENSES AT LEAST HAVE A CHILD THE\n      HUSBAND'S SPERMOGRAM SHOULD HAVE NO ABNORMALITIES THE  SUBJECT SHOULD HAVE A NORMAL\n      HYSTEROSALPHINGOGRAPHY\n\n      Exclusion Criteria:\n\n      HAVING ANY SYSTEMIC DISEASE. LONG HISTORY OF ANY DRUG USAGE.\n\n      THE STUDY INCLUDES THE FOLLOWING TESTS BEING DONE ON THE PATIENTS:\n\n      THE FOLLOWING HORMONES' LEVELS WERE STUDIED:AMH (ANTI-MULLERIAN HORMONE),FSH (FOLLICULAR\n      STIMULATING HORMONE) , E2 (ESTRADIOL)  AND INHIBIN B.THE FORMER THREE HORMONE LEVELS SHOULD\n      BE ASSESSED ON THE THIRD DAY OF MENSES IN THE STUDY,TRANSVAGINAL ULTRASONOGRAPHIC OVARIAN\n      VOLUME ,OVARIAN ANTRAL FOLLICULE NUMBER,OVARIAN STROMAL BLOODFLOW AND OVARIAN ARTERIAL\n      RESISTANCE WAS MEASURED USING DOPPLER ULTRASONOGRAM."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  LESS THAN 35 YEARS OLD,\n\n          -  MARRIED WOMEN\n\n          -  SHOULD HAVE  REGULAR MENSES\n\n          -  SHOULD HAVE AT LEAST A YEAR OF UNPROTECTED SEX.\n\n        Exclusion Criteria:\n\n          -  HAVING ANY SYSTEMIC DISEASE.\n\n          -  LONG HISTORY OF ANY DRUG USAGE."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "ALL STUDY PARTICIPANTS SHOULD BE LESS THAN 35 YEARS OLD, MARRIED , SHOULD HAVE  REGULAR\n        MENSES AND SHOULD HAVE AT LEAST A YEAR OF UNPROTECTED SEX."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02127944", 
            "org_study_id": "MS1"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "contact": {
                "email": "DRSULEYMANGUVEN@YAHOO.COM", 
                "last_name": "SULEYMAN GUVEN", 
                "phone": "+905325866944"
            }, 
            "facility": {
                "address": {
                    "city": "Trabzon", 
                    "country": "Turkey", 
                    "zip": "61080"
                }, 
                "name": "Ktu Farabi Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "2", 
        "official_title": "Assessment of Ovarian Reserve Tests in Unexplained Infertile Women", 
        "overall_contact": {
            "email": "DRSULEYMANGUVEN@YAHOO.COM", 
            "last_name": "SULEYMAN GUVEN", 
            "phone": "+905325866944"
        }, 
        "overall_official": {
            "affiliation": "KARADENIZ TECHNICAL UNIVERSITY -MEDICAL FACULTY  OBSTRETICS AND GYNAECOLOGY DEPARTMENT", 
            "last_name": "SULEYMAN GUVEN", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "AMH (ANTI-MULLERIAN HORMONE),FSH (FOLLICLE STIMULATING HORMONE),E2  (ESTRADIOL)AND INHIBIN -B LEVELS WILL BE TESTED", 
            "measure": "LEVELS OF OVARIAN RESERVE MARKERS IN THE SERUM", 
            "safety_issue": "No", 
            "time_frame": "ONE DAY"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02127944"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karadeniz Technical University", 
            "investigator_full_name": "Suleyman Guven", 
            "investigator_title": "Ass\u0131stant. Professor.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "OVARIAN ANTRAL FOLLICULE COUNT ,OVARIAN VOLUME MEASUREMENT,OVARIAN DOPPLER -ULTRASONOGRAPHIC ASSESSMENT", 
            "measure": "ULTRASONOGRAPHIC ASSESSMENT OF OVARIAN RESERVE MARKERS", 
            "safety_issue": "No", 
            "time_frame": "ONE DAY"
        }, 
        "source": "Karadeniz Technical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karadeniz Technical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}